Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Potent and selective COX-2 inhibitors synthesized at Boehringer Ingelheim

Sep. 16, 1997

PDL licenses antibody humanization patents to IDEC

Sep. 16, 1997

Pivotal data reported for ENBREL in severe RA

Sep. 12, 1997

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Sep. 12, 1997

RWJ-63556: dual COX-2/5-LO inhibitor effective in canine model of local inflammation

Sep. 12, 1997

IDEC licenses rights to novel antiinflammatory technology

Sep. 11, 1997

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

Sep. 11, 1997

Promising preliminary results obtained with Arthrovas in osteoarthritis

Sep. 10, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...